18 October 2024
According to Yulia Nechaeva, Research Director at DSM Group, the Russian pharmaceutical market has experienced growth since 2014, with projections indicating it will more than double by 2024.
“We see that the market continues to grow, although the structure of this growth is changing. If during the pandemic years the growth driver was government procurement, now the main contribution is made by the commercial segment – pharmacies and the population’s own expenses,” said Yulia Nechaeva.
The distribution segment showed relative stability, despite a slight decrease in concentration. The largest players have remained unchanged for 10 years. However, the opposite situation is observed in the pharmacy segment. “In 2024, 62% of the pharmacy market is concentrated in the hands of large players, while in 2014 this figure was only 15%,” she added.
Government procurement brand ratings have seen a 100% update over 10 years, with many 2014 positions absent in 2024. Russian manufacturers’ role has also increased. Yulia Nechaeva also voiced a forecast for the further development of the market, noting that the positive dynamics will continue in the future.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024